The American Cancer Society estimates that about 67,440 Americans (34,950 men and 32,490 women) will be diagnosed with ...
A rapid nanosensor assay that measures serum protease cleavage of a target-probe nanosensor can identify pancreatic du ...
The study shows an almost 80% drop in rates of cervical precancers among women ages 20-24 from 2008 to 2022, correlating to vaccine uptake. Simultaneously, an mRNA pancreatic cancer vaccine is showing ...
Half of all pancreatic cancer patients live less than a year after diagnosis. But researchers say there is potential for ...
The group recently published a case-control study showing high sensitivity and specificity, with little drop in early-stage disease, compared to late-stage cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback